---
$id: https://graph.org.ai/products/commodity/51111739
$type: Product
source: UNSPSC
code: "51111739"
title: "Etoposide"
class: "51111700"
classTitle: "Antineoplastic antibiotics"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Etoposide

**UNSPSC Code**: 51111739
**Class**: [Antineoplastic antibiotics](Antineoplastic antibiotics.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an epipodophyllotoxin compound, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6PLQ3CP4P3. European Medicines Agency schedules Etoposide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07337MIG. Etoposide generally arises in the molecular formula C29H32O13. The term ETOPOSIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, no. 10 1976, list 16.) ETOPOSIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etoposide under HS 29389090 and SITC 54161. As of Q4 2014, ETOPOSIDE remains the US FDA Preferred Term for this commodity. Etoposide bears US NLM identifiers UMLS ID C0015133 and NCI Concept Code C491. SMILES: O(C1C2C(C(C3C1CC1OCOC1C3)C1CC(OC)C(O)C(OC)C1)C(=O)OC2)C1OC2C(OC(OC2)C)C(O)C1O.

